ROSE RAMIREZ: Open Payments
NPI 1972565398 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,961 in 197 payments from 21 companies in 2025. Trend: 2023 $3,158 · 2024 $4,143 · 2025 $4,961
Food & beverage: $4,074Travel & lodging: $887
| Company | Payments | Amount |
|---|---|---|
| Enterra Medical, Inc. | 5 | $1,297 |
| ABBVIE INC. | 66 | $1,232 |
| Janssen Biotech, Inc. | 14 | $238 |
| Madrigal Pharmaceuticals | 9 | $216 |
| PFIZER INC. | 10 | $213 |
| Gilead Sciences, Inc. | 11 | $211 |
| GENZYME CORPORATION | 10 | $211 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $197 |
| Aimmune Therapeutics, Inc. | 9 | $188 |
| Ipsen Biopharmaceuticals, Inc | 12 | $170 |
Products named: RINVOQ, CREON, DUPIXENT, TREMFYA, REZDIFFRA, ENTYVIO, ZENPEP, IQIRVO.
Industry payments across OK — which companies pay providers there.
